Roche moved to enter the booming weight-loss drug market now dominated by Novo Nordisk and Eli Lilly. The Swiss ...

People without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide (Mounjaro) as an off-label ...

Eli Lilly has recently unveiled significant advancements across its product line, including promising results from the BRAVE-AA-PEDS study on adolescents ... to build four new manufacturing ...

the company's decision to construct new manufacturing sites in the U.S., creating thousands of jobs, indicates an aggressive expansion strategy. Such advances likely contributed to Eli Lilly's ...

New results show Eli Lilly (LLY) and Company’s Ebglyss achieved deep and sustained response for patients with moderate-to-severe atopic ...

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

We recently compiled a list of the 10 Best Low Risk Stocks To Buy in 2025. In this article, we are going to take a look at ...

It's hard to argue with the kinds of results Eli Lilly ... Naturally, other new Lilly products could see the light of day by ...

Advertisement Eli Lilly chairman and Chief Executive Officer ... long after they've rejoined their sport, a new study says. Health News // 8 hours ago Sugary drinks linked to greater oral cancer ...